Taken together, these findings provide compelling evidence that TRAF3-induced lipid peroxidation enhanced the susceptibility of GBM cells to ferroptosis-inducing agents and anti–PD-L1 immunotherapy, suggesting a promising therapeutic strategy for GBM. The gene discussed is CD274; the disease is glioblastoma.